selected publications

• academic article

  • Factors affecting visual outcomes in patients with diabetic macular edema treated with ranibizumab..  Eye (London, England).  28:269-278. 2014
  • Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment..  JAMA ophthalmology.  131:139-145. 2013
  • Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study..  Ophthalmology.  117:2146-2151. 2010
  • Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study..  Ophthalmology.  116:2175-81.e1. 2009